Related Experiment Video
Updated: Jul 29, 2026
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Racial differences in platelet survival time in patients with symptomatic coronary atherosclerosis
Arteriosclerosis (Dallas, Tex.)
|March 1, 1983
Summary
Platelet survival is significantly shorter in white patients with coronary artery disease compared to black patients. Race is a key factor influencing platelet consumption and should be considered in cardiovascular studies.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Medical Research
Background:
- Coronary artery disease (CAD) and angina pectoris affect diverse populations.
- Platelet function and survival are critical in thrombotic processes associated with atherosclerosis.
- Existing research suggests potential racial disparities in cardiovascular disease progression.
Purpose of the Study:
- To investigate the impact of race on platelet survival times in patients with stable coronary artery disease.
- To compare platelet survival between white and black patients with CAD and healthy controls.
- To identify factors influencing shortened platelet survival in this patient cohort.
Main Methods:
- Platelet survival time analysis was conducted in 40 patients (21 white, 19 black) diagnosed with CAD and stable angina.
- Comparison of mean platelet survival times between patient groups and control groups (19 white, 12 black).
- Statistical analysis, including stepwise multiple linear regression, was employed to determine significant predictors of platelet survival.
Main Results:
- White patients with CAD exhibited significantly shorter platelet survival times compared to both white and combined control groups (p < 0.01).
- Platelet survival times in black patients with CAD were not significantly different from control groups.
- Race was identified as the most significant factor predicting shortened platelet survival (r = 0.4783; p < 0.01), with white patients showing shorter survival than black patients (p < 0.01).
Conclusions:
- Racial background is a significant determinant of platelet survival in patients with coronary artery disease.
- Observed racial differences in platelet survival may contribute to disparities in atherosclerotic lesion development and progression.
- Platelet consumption rates may differ between racial groups, impacting cardiovascular disease risk and necessitating consideration in clinical interpretation and research.
Related Concept Videos
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...